TL;DR: "the risk of wearing Glass appears to be low", according to a Eli Peli, who has been "con$ulting with the Glass team for nearly two years."
Slashdot videos: Now with more Slashdot!
they need to figure out a way to make it unhackable for it to be truly reliable, but that isn't an impossible task.
You speak in absolutes. I'm not sure if I should smile because of your optimism, or point out your ignorance of all the other historic "unhackable" claims that have fallen.
Seriously. Just give me a Bash shell. I'll alias some useful stuff to short commands. Voice dictation can reduce the safety issues with keyboard use. And when the car is out of warranty, the dealer has to add me to the wheel group for sudo.
TFA claims that Sony's new CSO, Brett Wahlin, "served as a counter-intelligence officer in the US Military for eight years during the Cold War." The final year of the cold war is generally agreed to be 1991, when the Soviet Union dissolved. This suggests he started working as a C-I officer no later than 1984. Yet the photo in his recent bio suggests he's in his early 40s now. So either 1) he's a prodigy and worked for the US military during high school, or 2) he can travel in time. Either way, the hacktivists might have met their match! Well played, Sony.
And add another server to the pool at http://thereifixedit.failblog.org/
then only outlaws will have cell phones in prisons.
written a two-part essay exploring why there is no pipeline of self-taught
female engineers entering the tech industry via Open Source or other
individual efforts. In "The Hidden Engineering Gap" , she asks why
there are so many self-taught male software engineers in startups, but
no similar pool of women. In "A Modest Proposal" , she discusses a
potential short-term fix to the problem.
""I think DCA can be selective for cancer because it attacks a fundamental process in cancer development that is unique to cancer cells," said Dr. Evangelos Michelakis, a professor at the University of Alberta department of medicine and a key study author.
The molecule appears to repair the damage that cancer cells cause to mitochondria, the units that convert food into energy."
"In addition, because DCA has been used in both healthy people and ailing patients with mitochondrial diseases, researchers know it is a relatively non-toxic molecule that can be immediately tested in patients with cancer.
The compound, which is sold both as powder and as a liquid, is widely available at chemistry stores.
Furthermore, the compound is not patented, nor is it owned by any drug firm, so it would be an inexpensive drug to administer.
However, because DCA is not patented, Michelakis expressed concern that it may be difficult to find funding from private investors to test the compound in clinical trials. ""